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Abstract 
 
Oligodendrocytes (OLs) are macroglial cells present in the vertebrate central nervous system (CNS). 
OLs are responsible for myelinating the neurons, ensuring an efficient propagation of electrical 
impulses along the axon, through saltatory conduction. Myelination disorders, such as multiple 
sclerosis, damage the myelin sheath and disrupt the normal performance of neurons. When this kind of 
event happens, OLs have the capability of remyelinating the affected axons for a certain period. 
Oligodendrocytes are originated by oligodendrocyte progenitor cells (OPCs), which are highly 
proliferative, as identified by the expression of the specific molecular marker platelet-derived growth 
factor receptor alpha (Pdgfra). OPCs proliferate in three phased developmental waves from different 
domains in the ventricles of the developing brain and spinal cord, giving rise to twelve distinct 
subpopulations of OLs. These proliferation waves occur in distinct time-points, namely on embryonic 
(E) days 13.5 and 15.5, and gradually throughout a postnatal (P) wave that starts at birth. Bulk and 
single-cell RNA-seq analysis performed by the host laboratory suggests that OPCs and OLs present a 
high degree of heterogeneity at transcriptional level: the gene expression profile of OPCs and progeny 
varies dramatically during development between and within different areas of the CNS. Thus, it was 
possible to identify putative cell markers for the twelve different OL subpopulations. To validate these 
markers in tissue sections, antibodies and RNA probes were tested through immunohistochemistry 
(IHC) and RNAscope in situ hybridization (ISH), respectively. Since the proliferation waves of OPCs 
occur in three different time points, the developmental origin of the distinctive OL subpopulations was 
also investigated both in the brain and spinal cord. This subject was addressed by conducting lineage 
tracing experiments using the PdgfrCreER-RCE mouse line, tagging GFP (green fluorescent protein) 
reporter with OPCs and their progeny. Recombination of the reporter gene was induced either on 
E12.5 or P3-5, in order to respectively target the first embryonic and postnatal waves of OPC 
proliferation and their progeny. Subsequently, brain and spinal cord were collected at different ages 
(P20 and P60), and IHC and ISH assays were performed to test the putative markers for different 
subpopulations of OL lineage. In this work, the pattern of expression of antibodies/probes for cellular 
markers of OL subpopulations was analysed: MOL1 and MOL2 in the juvenile mouse, and MOL5/6, 
OPCs/COP in the adult mouse. Moreover, colocalization of signal between diverse cellular markers 
for OL lineage was assessed in the adult mouse, targeting the embryonic and postnatal waves of OPC 
proliferation and progeny. The results presented in this work contribute for a broader comprehension 
regarding OL lineage heterogeneity, as well as their developmental origin in the CNS of the mouse. 
 
Keywords: Oligodendrocyte, oligodendrocyte progenitor cell, developmental wave, heterogeneity, cell 
marker 
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Resumo 
 
O sistema nervoso é uma complexa rede de células especializadas que comunicam entre si, permitindo 
ao organismo adquirir e partilhar informação sobre o próprio e o que o rodeia. Isto envolve 
componentes sensoriais que detectam estímulos ambientais, e componentes motores que comandam os 
diferentes músculos, bem como secreções glandulares. A rede que constitui o sistema nervoso é 
composta por neurónios e células especializadas, denominadas células da glia, ou simplesmente glia. 
A sinalização entre estes diferentes tipos celulares permite a realização de processos cognitivos como 
o pensamento, comunicação, aprendizagem e formação de memórias, e também a movimentação e 
sensação. Isto permite a percepção e interação com o mundo, outros indivíduos e si mesmo, moldando 
o próprio comportamento. Ao longo do desenvolvimento do sistema nervoso, factores de crescimento 
irão induzir a formação da espinal medula, posteriormente levando à origem do cérebro. A 
proliferação e diferenciação de células estaminais neurais, que são multipotentes, levará à geração de 
neurónios e glia no sistema nervoso. Os neurónios são o componente básico para o funcionamento do 
cérebro, espinal medula e nervos periféricos, sendo o principal tipo celular do sistema nervoso. Estas 
células comunicam entre si através da condução de impulsos nervosos ao longo do axónio e graças à 
existência de conexões entre si, denominadas sinapses. Para além disso, as célula da glia têm também 
papéis cruciais para o correto funcionamento do sistema nervoso central (SNC), incluindo proteção 
imunológica no caso da microglia, suporte metabólico e recaptação de neurotransmissores no caso dos 
astrócitos, e os oligodendrócitos são responsáveis pela mielinização dos neurónios.  
 
Os oligodendrócitos (OLs) interagem com axónios adjacentes, através da projeção de diversos 
processos celulares,  envolvendo-os em mielina. A bainha de mielina fornece suporte aos neurónios e 
facilita a propagação de impulsos eléctricos de forma rápida e eficiente, através de condução 
saltatória. Tendo em conta que a mielinização neuronal está relacionada com aspectos 
comportamentais, cognitivos e emocionais, este trata-se de um processo crucial para o correto 
funcionamento do cérebro humano. Um dos aspectos mais característicos da mielinização é que 
começa no estado embrionário e estende-se após o nascimento, em humanos ao longo das duas 
primeiras décadas de vida, e em ratinho até aos dois meses. No entanto, a produção de mielina 
também pode acontecer noutras alturas da vida, nomeadamente em contexto de doenças que 
comprometam o funcionamento dos OLs ou danifiquem as bainhas de mielina já existentes, como é o 
caso da esclerose múltipla. Cada OL tem a capacidade para mielinizar cerca de 60 axónios distintos, 
dependendo do área do SNC e diâmetro dos axónios. Os OLs são originados por células progenitoras 
de oligodendrócitos (OPCs), que são altamente migratórios, como identificado pela expressão dos 
marcadores moleculares específicos proteoglicano NG2 e platelet-derived growth factor receptor alfa 
(Pdgfra). Ao longo do desenvolvimento e durante episódios de remielinização a linhagem dos OLs 
diferencia-se progressivamente e de forma altamente regulada. Estes processos são controlados por 
uma multitude de factores moleculares intrínsecos e extrínsecos, que induzem alterações epigenéticas 
e regulação transcricional e traducional em OPCs e OLs, orquestrando assim a produção de mielina.  
 
A origem dos OPCs ocorre em ondas de proliferação sequenciais, provenientes de domínios dorsais e 
ventrais do cérebro e espinal medula em desenvolvimento. Em ratinho, a primeira onda de produção 
de OPCs ocorre sensivelmente no dia embrionário (E) 13.5, seguido por uma segunda onda no dia 
E15.5. Uma terceira, e última, onda de proliferação ocorre após o nascimento, e gradualmente ao 
longo de alguns dias. Experiências de fate-mapping demonstram que na espinal medula os OPCs têm 
fundamentalmente origens ventrais, contribuindo em 85-90% para a origem de OLs no ratinho adulto. 
Por outro lado, no cérebro, a primeira onda de proliferação de OPCs é essencialmente reposta por 
precursores originados de zonas mais dorsais, numa fase posterior do processo de desenvolvimento. 
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Curiosamente, a ablação génica de células precursoras tanto de origem ventral como dorsal resulta 
numa expansão compensatória da população contrária, originando um número final de OLs e níveis de 
mielinização normais, o que demonstra um grande grau de redundância. Para além disto, os OPCs são 
também capazes de comunicar com neurónios, através de potenciais de ação, demonstrando 
funcionalidade equivalente em OPCs originados tanto de zonas ventrais como dorsais. Apesar de a 
população de OLs  aparentar ser altamente homogénea na sua função, os OPCs estão aptos a gerar 
OLs com potencial de mielinização heterogéneo. No caso da espinal medula, os OLs produzem 
bainhas de mielina mais espessas e os segmentos internodais nos axónios são mais longos, 
contrariamente aos OLs corticais. Para além disso, OPCs da matéria branca diferenciam-se em OLs 
mielinizantes quando transplantados tanto para matéria branca como cinzenta, o que não acontece com 
OPCs da matéria cinzenta, gerando menos OLs produtores de mielina mesmo quando transplantados 
para matéria branca. Assim, é preciso clarificar se os OLs se tornam morfologicamente diversificados 
ao longo da maturação, através de interações com o meio envolvente, ou se possuem heterogeneidade 
funcional intrinsecamente.   
 
A esclerose múltipla é uma doença crónica autoimune no sistema nervoso central, caracterizada por 
surtos de desmielinização neuronal com diversos níveis de gravidade. Julga-se que seja causada por 
diversos factores, nomeadamente susceptibilidade genética, infeção viral, desestabilização no 
metabolismo e fatores ambientais. Carateriza-se pela perda de força muscular, alterações na 
coordenação e sensibilidade, visão enevoada e dificuldades no discurso. Normalmente é desencadeada 
entre os 20 e os 45 anos de idade e, de momento, não tem cura. Na maioria dos pacientes, a esclerose 
múltipla apresenta estádios iniciais de deficits neurológicos reversíveis, quando os sintomas abrandam 
ou desaparecem, o que corresponde a uma resposta remielinizante dos OPCs. No entanto, ao longo do 
tempo os OPCs vão perdendo a capacidade de responder de forma eficiente até que acabam por perder 
a sua função na totalidade. Este padrão designa-se relapse-remitting e é o subtipo mais comum da 
doença. A remielinização normalmente segue-se a uma perda patológica de mielina, de forma a 
restaurar as propriedades dos neurónios através da produção de novas bainhas de mielina. Este é um 
processo complexo que envolve factores celulares e moleculares na sua regulação. Numa fase inicial 
as áreas afectadas são colonizadas pelos OPCs, que depois se diferenciam em OLs mielinizantes, que 
contactam com os axónios afectados e produzem novas bainhas de mielina funcionais. Foi 
demonstrado anteriormente que o transplante de OPCs no SNC origina oligodendrogénese e 
consequente remielinização axonal. Desta forma, os OPCs são a população celular que deve ser focada 
para o desenvolvimento de novas terapias para doenças desmielinizantes. 
 
Análise de sequenciação de RNA (RNA-seq) em bloco e célula a célula, sugere que os OPCs e OLs 
possuem um elevado grau de heterogeneidade a nível transcricional. Foram analisados 5072 
transcriptomas de células singulares, isolados de 10 regiões específicas do SNC de ratinho juvenil e 
adulto, sendo identificadas 12 subpopulações distintas da linhagem de OLs. Foi também possível criar 
um modelo de diferenciação, partindo dos OPCs e identificando as diversas fases dos OLs até 
atingirem o estado maduro. A existência destes estados distintos de OPCs e OLs sugerem uma 
possível heterogeneidade funcional. Assim, foi também possível criar uma lista de marcadores 
celulares putativos para a identificação das diferentes subpopulações de OLs presentes no cérebro e 
espinal medula do ratinho. De forma a validar estes marcadores em secções de tecido do SNC de 
ratinho, usaram-se anticorpos e sondas de RNA, testados respetivamente através de técnicas de imuno-
histoquímica (IHC) e hibridização in situ (ISH). Para além disso, e tendo em conta que as ondas de 
proliferação de OPCs ocorrem em três fases distintas, também se procedeu à investigação da origem 
do desenvolvimento das diferentes subpopulações de OLs, tanto no cérebro como na espinal medula. 
Estes estudos foram feitos recorrendo a lineage tracing, utilizando a linhagem de ratinho 
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PdgfraCreER-RCE, induzindo, através de injeções de tamoxifeno, a expressão do gene repórter GFP 
(green fluorescent protein) nos OPCs e respetiva descendência. Induziu-se a recombinação e 
expressão de GFP nos dias 12.5 do estado embrionário ou 3-5 após o nascimento do ratinho, pondo em 
evidência respetivamente a primeira ou última ondas de proliferação de OPCs e descendência. 
Subsequentemente, o cérebro e espinal medula foram recolhidos em idades distintas, nomeadamente 
no ratinho juvenil (20 dias) e adulto (60 dias), e realizaram-se ensaios de IHC e ISH. Neste trabalho 
foi analisado o padrão de expressão de marcadores celulares, através da utilização de 
anticorpos/sondas específicos, de subpopulações de OLs: MOL1 e MOL2 no ratinho juvenil, e 
MOL5/6, OPCs/COP no ratinho adulto. Procedeu-se ainda à análise de co-localização de sinal entre 
diversos marcadores celulares da linhagem de OLs no ratinho adulto. Os resultados apresentados neste 
trabalho contribuem para uma maior compreensão sobre a heterogeneidade da linhagem de OLs, bem 
como a sua origem ao longo do desenvolvimento do SNC do ratinho. A aquisição desta informação 
poderá ser útil no sentido de melhor compreender as alterações moleculares e de diferenciação de 
OPCs e OLs em eventos de remielinização em contexto de doenças desmielinizantes, como a esclerose 
múltipla. 
 
Palavras-chave: Oligodendrócito, célula precursora de oligodendrócitos, onda de desenvolvimento, 
heterogeneidade, marcador celular 
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Introduction 
 
Nervous system, a complex and dynamic network 
 
The nervous system is a complex network of specialized cells that communicate with each other, 
enabling the organism to acquire and share information about its surroundings and itself. This involves 
sensory components, which detect environmental stimuli, motor components that operate skeletal, 
cardiac and smooth muscles, and also mechanisms that regulate glandular secretions (Kandel et al., 
2013). These extremely intricate processes ensure that the homeostasis of the individual is properly 
sustained, by managing inputs that come from either an internal or external source, and delivering 
adjusted outputs to specific areas within the organism. Evolutionarily, higher-class organisms have 
their nervous system broadly divided in central nervous system (CNS), composed by the brain and 
spinal cord, and peripheral nervous system (PNS), which branches throughout the body and connects 
the CNS to limbs and organs (Byme et al., 2014). The network that forms the nervous system is 
composed of neurons and specialized cells named glial cells or glia, which differ between the CNS 
and PNS. The signalling between these cell-types and structures enables cognitive processes such as 
thinking, communicating, learning and memory storing, as well as all function and sensation. This 
allows the perception and interaction with the world, other individuals and itself, shaping one’s own 
behaviour (Squire et al., 2008). 
 
Due to the high structural and functional complexity of the nervous system, the developmental process 
that starts during the embryonic stage and prolongs itself throughout adulthood involves tightly 
regulated cellular and molecular mechanisms. During early embryogenesis, all the tissues and cell-
types that will later be formed are originated from three germ layers, namely endoderm, mesoderm 
and ectoderm, which are generated during a process termed gastrulation (Mtui, E., Gruener, G., & 
Fitzgerald, 2011; Zuchero and Barres, 2015). Each cell layer gives rise to specific tissues – endoderm 
forms the digestive tube lining, mesoderm develops into muscle, bone and connective tissue, and 
ectoderm generates the nervous system, as well as skin and hair. Following gastrulation, the notochord 
– a flexible, rod-shaped structure that runs along the back of the embryo – has been formed from the 
mesoderm and then releases molecular signals to the overlying ectoderm. This induces its 
differentiation into neuroectoderm and the formation of the neural plate, which consists on a strip of 
neuronal stem cells (NSCs) that originate the nervous system. The neural plate then folds in upon 
itself, forming the neural tube, which later develops into brain and spinal cord. The PNS develops 
from the neural crest, located in the dorsal border of the neural tube, presenting cell migration and 
differentiation at a later stage (Gilbert, 2010; Kandel et al., 2013). 
 
During the development of the spinal cord, growth factors, also known as morphogens, are released 
and induce the formation of motor areas ventrally and sensory areas dorsally. This differentiation 
occurs due to the concentration gradients formed by the morphogens, which take part in many 
processes during embryogenesis and throughout development until adulthood (Decimo et al., 2012). 
Later on, the brain is formed in a similar fashion, developing from primordial structures – 
prosencephalon, mesencephalon and rhombencephalon. These three areas progressively change, 
giving rise to telencephalon and diencephalon, which derive from the prosencephalon and become the 
forebrain, the mesencephalon develops into midbrain, and lastly the rhombencephalon matures into 
metencephalon and myelencephalon to form the hindbrain (Gilbert, 2010). Meanwhile, there is 
proliferation of neural stem cells (NSCs), which are self-renewing, multipotent cells that generate the 
neurons and glia of the nervous system. During embryonic development of vertebrates, NSCs of the 
central nervous system are named radial glial cells, and are localized in a transient area known as 
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ventricular zone (VZ). Both neurons and glial cells differentiate and migrate from this area to other 
places in the CNS, progressively establishing the neural circuits. The ventricular zone eventually 
subsides but there are other niches of NSCs that are maintained after birth, such as the subventricular 
zone (SVZ) and the dentate gyrus of the hippocampus, where neurogenesis still occurs throughout 
adulthood (Campbell and Götz, 2002; Nadarajah et al., 2003). Therefore, based on chemical signalling 
and molecular crosstalk, the adult brain has the capability of generating novel neurons and glial cells if 
needed, which conveys a certain degree of adaptability and plasticity, essential for survival (Decimo et 
al., 2012).   
 
Neurons are the core components of the brain, spinal cord and peripheral nerves, being the main cell-
type of the nervous system. These cells generate, process and transmit information by conducting 
electrical impulses over the axon and by forming connections, named synapses, between themselves 
and other tissues (Byme et al., 2014). Sensory neurons are responsive to external stimuli, such as 
touch, sound or light, and send signals to the spinal cord and brain, while motor neurons receive 
signalling from the CNS, causing muscle contractions and affecting glands (Kandel et al., 2013). Glial 
cells display different subtypes, whose roles include immunological protection, metabolic and 
structural support, and neuronal insulation. Glia constitutes 50-60% of the cells in the adult mouse 
brain and up to 90% in the adult human brain, which is an indicator that glial cells posed crucial roles 
for the increase of complexity in neurological function throughout evolution (Herculano-Houzel, 
2014; Rowitch, 2004). This data joined with on-going investigation has shattered the previous view 
that glial cells were secondary in the CNS, merely forming a binding support network without any 
other relevant tasks associated. It is now known that the two groups of glia, namely microglia and 
macroglia, display important specific roles, morphologies and developmental origin (Rowitch and 
Kriegstein, 2010). 
 
 
Oligodendrocytes, myelinating cells of the CNS 
 
Oligodendrocytes (OLs) are glial cells that branch out numerous processes, which interact with nearby 
axons, enveloping them in myelin (Fig. 1). The myelin sheath is an insulation that results from 
modified plasma membrane, being primarily composed of lipids and proteins (Simons and Nave, 
2015). By ensheathing the axon, this fatty structure provides support to neurons and promotes the 
rapid and efficient propagation of electrical impulses. These impulses are transmitted along the axon 
by saltatory conduction, where action potentials are regenerated at unmyelinated nodes of Ranvier 
rather than being propagated in a linear manner (Bauer et al., 2009). Neuronal myelination is linked 
with behavioural, cognitive and emotional aspects, therefore the efficiency of this process is crucial 
for the normal performance of the mature human brain.  
 
One of the most striking features about the myelinating process is that it unfolds mainly at a later stage 
of neuronal development, over a prolonged time frame. In humans, it progresses during the first two 
decades of life, while in mice it takes place over the first two postnatal months (Lebel et al., 2008; 
Mitew et al., 2014). However, myelination also occurs throughout life, either to substitute lost OLs 
and myelin or to myelinate axons that were previously unmyelinated (Bartzokis et al., 2012). There is 
also evidence of experience-driven plasticity in the myelination process, which includes learning and 
cognitive stimulation. In fact, extensive long training of motor activities, such as playing a musical 
instrument or juggling, correlates with an increase in white matter volume in areas of the brain that are 
active during the performance of these tasks (Bengtsson et al., 2005; Scholz et al., 2009). Thus, the 
	 3	
amount of neuronal activity is another important factor in the modulation of myelin production in the 
CNS (Ishibashi et al., 2006). 
 
A single OL can myelinate up to 60 different axons, depending on the specific tract and axonal 
diameter, and the production of adjacent myelin segments in the axon is performed by distinct OLs 
(Baumann and Pham-Dinh, 2001; Miller, 2002). In contrast, the myelinating cells in the PNS, known 
as Schwann cells, display a different morphology, consisting of a single myelin segment. They are 
organized in tandem along the axon and form nodes of Ranvier between them, enabling saltatory 
conduction of electrical impulses (Baumann and Pham-Dinh, 2001). Most OLs are located in white 
matter, hence the high levels of myelination in these areas of the CNS. On the contrary, grey matter 
consists of numerous neuronal cell bodies and fewer axons, myelinated to a lesser degree (Ohtani et 
al., 2014). Since myelin constitutes up to 50% of the human adult brain volume, injuries or diseases 
that affect its structure or production, such as multiple sclerosis, can cause loss of neurological 
function and the life span of the individual might be dramatically affected (Miller, 2002). 
 
 
     
 
Figure 1. Morphology of oligodendrocyte cells. A) Oligodendrocytes project cellular processes and branches that follow 
the orientation of nerve fibres, forming complex wraps. B) Fluorescent staining of oligodendrocytes expressing proteolipid 
protein (PLP) tagged to green fluorescent protein (GFP). (Adapted from Simons and Nave, 2015). 
 
 
Origin and proliferation of oligodendrocyte progenitor cells 
 
Oligodendrocytes are generated by oligodendrocyte progenitor cells (OPCs), which constitute 5-8% of 
the total number of cells in the human adult CNS (Richardson et al., 2011). In rodents, the OL 
developmental program starts with the specification of OPCs derived from neural stem and progenitor 
cells during late embryonic gestation. OPCs are highly migratory and proliferative, as identified by the 
expression of specific molecular markers NG2 proteoglycan and platelet-derived growth factor 
receptor alpha (Pdgfra) (Baumann and Pham-Dinh, 2001; Bercury and Macklin, 2015). Throughout 
development and during remyelination events, the oligodendrocyte lineage progressively differentiates 
in a tightly regulated manner. These processes are controlled by a multitude of intrinsic and extrinsic 
molecular cues, which orchestrate myelination both spatially and temporarily. These signals are 
mainly growth factors, kinases and extracellular matrix molecules, all of which influence epigenetic 
A B 
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modifications, transcriptional and translational regulation, and cytoskeleton dynamics in OPCs and 
OLs (Fig. 2) (Bercury and Macklin, 2015; Miller, 2002).  
 
 
 
 
Figure 2. Model of the differentiation of a committed oligodendrocyte progenitor cell (OPC) into a mature 
myelinating oligodendrocyte. Until initial contacts are stabilized, OPCs extend and retract cellular processes. In the lower 
half of the figure, the myelin sheath is represented with an unrolled structure. Maturation of the nodes of Ranvier requires the 
glia-dependent clustering of axonal voltage-gated ion channels, depicted in the upper half of the figure. (Adapted from Nave 
et. al, 2014) 
 
 
The developmental origin of OPCs occurs in sequential proliferation waves from different ventral and 
dorsal domains of the developing brain and spinal cord, influenced by several cellular factors 
(Richardson et al., 2006) (Fig. 3). In mice, the first wave of OPC production takes place around 
embryonic day (E) 13.5 in the progenitor niche of the ventral neuroepithelium of the developing spinal 
cord (Lu et al., 2000) and in the medial ganglionic eminence of the ventral ventricular zone of the 
telencephalon (Tekki-Kessaris et al., 2001). This is followed by a second wave of OPC genesis at 
E15.5, from the dorsal region of the developing spinal cord (Cai et al., 2005) and from the lateral and 
caudal ganglionic eminences of the ventral VZ of the telencephalon (Kessaris et al., 2006). A third 
wave takes place after birth, however its specific origins – whether from progenitor cells around the 
central canal or from proliferative OPCs – remain unclear in the SC (Rowitch and Kriegstein, 2010) 
and are originated mainly from the subventricular zone, in the brain (Aguirre et al., 2007). During the 
postnatal development of the brain, OPCs migrate from the SVZ to other regions, where they stop 
dividing and differentiate into mature myelinating OLs (Menn et al., 2006).  
 
Fate-mapping experiments show that, in the spinal cord, OPCs have fundamentally ventral origins, 
with ventrally derived cells accounting for 85-90% of adult OLs. In contrast, the first wave of 
proliferation in the brain is essentially replaced by more dorsally generated precursors at a later stage 
of the developmental process. Interestingly, genetic ablation of precursors of both ventral and dorsal 
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origin results in the compensatory expansion of the opposing population, conveying a regular final 
number of OLs and myelin, showing a large degree of redundancy (Kessaris et al., 2006; Richardson 
et al., 2006). Additionally, OPCs are capable of communicating with neurons through action potentials 
(Maldonado et al., 2013; Tomassy and Fossati, 2014), showing functionality, and both ventrally- and 
dorsally-generated precursors present similar electrophysiological properties (Tripathi et al., 2011). 
 
 
 
 
Figure 3. Multiple waves of OPC proliferation during the development of the mammalian CNS. A) Three sequential 
waves of OPCs (OPC 1, OPC 2 and OPC 3) arise from specific domains in the forebrain ventricular zone. OPC 1 arises at 
E13.5, OPC 2 starts at E15.5 and OPC 3 begins at birth. B) Two distinct waves of OPCs emanate from the ventral region and 
dorsal region of the spinal cord (OPC1 – E13.5; OPC 2 – E15.5), while the origins of the third wave remain unclear (OPC3 – 
starts at birth).  (Adapted from Rowitch and Kriegstein, 2010). 
 
 
Remyelination during multiple sclerosis 
 
Multiple sclerosis (MS) is a chronic autoimmune inflammatory neurological disease of the CNS that 
attacks neurons and destroys myelin to various degrees (Lassmann et al., 2001). Even though the 
cause is unknown, it appears to involve a combination of genetic susceptibility and non-genetic 
triggers, such as viral infections, metabolic disorders or environmental factors. The symptoms include 
muscle weakness, changes in coordination and sensibility, blurred vision, speech difficulties, fatigue, 
among others (Compston and Coles, 2008). Its onset usually happens in adults between 20 and 45 
years of age, and occasionally during childhood or late middle age. At the moment, there is not a cure 
for MS and the available treatments are based on the improvement of function after an attack and 
preventing new occurrences (Chari, 2007; Goldenberg, 2012). 
 
Besides inflammation and loss of myelin, MS lesions also present different levels of astrogliosis, 
phagocytic activity, oligodendroglial loss and axonal pathology (Lassmann et al., 2001). However, in 
most patients, MS initially presents stages of reversible neurological deficits, when symptoms improve 
or disappear, corresponding to a local response from OPCs and remyelination to a certain degree. 
Eventually, as disease episodes recur over time, remyelination occurs with increasingly lower 
efficiency and eventually fails in the majority of the cases. This pattern is known as relapsing-
remitting MS, a sub-type of the disease that affects about 85% of patients (Barnett and Prineas, 2004; 
Bjartmar and Trapp, 2001). 
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Remyelination usually follows a pathological loss of myelin, in order to restore the properties of 
neurons by producing new myelin sheaths around damaged axons of the CNS. This is a complex 
process that involves interdependent cellular and molecular factors in its regulation and occurs in two 
major phases. Affected areas are colonized by OPCs, which then differentiate into myelinating OLs 
that contact impaired axons and produce novel functional myelin sheaths (Chari, 2007). It has been 
previously shown that transplantation of OPCs in the CNS results in oligodendrogenesis and 
consequential axonal remyelination, while transplanted mature OLs fail to remyelinate the axons in 
the new surrounding area (Hans S Keirstead, 1999). This demonstrates that OPCs are the cell 
population that should be targeted in order to achieve remyelination, presenting a novel therapy for 
demyelinating diseases.  
 
 
Oligodendrocytes display heterogeneity 
 
It is well established that OPCs and OLs are extremely important in order to sustain a proper axonal 
myelination. Even though the OL population in the CNS is thought to be highly homogeneous in 
function (Kessaris et al., 2006), these cells were firstly described as morphologically heterogeneous 
(del Río-Hortega, 1928). Indeed, OPCs are capable of generating OLs with distinct innate 
heterogeneous myelination potential, as OLs in the spinal cord produce thicker myelin sheets and 
longer internode segments compared to cortical OLs (Bechler et al., 2015). Furthermore, while white 
matter OPCs differentiate into myelinating OLs when transplanted both in the white or grey matters, 
grey matter OPCs do not generate as many myelinating OLs, even when transplanted into white 
matter. Therefore, it is not clear whether OLs become morphologically diversified throughout 
maturation from interactions within the local environment or whether there is an intrinsic functional 
heterogeneity (Bechler et al., 2015; Tomassy and Fossati, 2014). 
 
Thus, while cells are proliferating they undergo continuous morphological and functional changes, 
which are orchestrated by an intricate programming of gene expression and a myriad of internal and 
external signalling molecules. Even though this biological dynamism makes defining a cell-type a 
delicate task, the host laboratory tackled this issue by using single-cell RNA-seq. This enabled the 
acquisition of the transcriptional background of thousands of individual cells and identification of 
existing RNA molecules. Some of these molecules are only present in a given number of cells, which 
were analysed and categorized as a certain subpopulation (Trapnell, 2015; Zeisel et al., 2015). 
 
Bulk and single-cell RNA-seq analysis of the host laboratory suggest that OPCs and OLs present a 
high degree of heterogeneity at transcriptional level: the gene expression profile of OPCs varies 
dramatically during development between and within different parts of the CNS. Moreover, cells of 
the oligodendrocyte lineage present distinct transcriptional profiles within the same brain region 
(Marques et al., 2016; Zeisel et al., 2015). The host group analyzed 5072 transcriptomes of single cells 
expressing molecular markers from the OL lineage, which were isolated from 10 specific regions of 
the mouse juvenile and adult CNS, identifying 13 distinct cell populations (Fig. 4). Moreover, t-
distributed stochastic neighbour embedding (t-SNE), supported by pseudotime analysis, presented a 
narrow differentiation path, establishing a connection between OPCs and myelin-forming 
oligodendrocytes, which then diversify into six mature states (Fig. 5) (Marques et al., 2016). 
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Figure 4. Single cell RNA-Seq reveals 12 subpopulations of OLs and a VLMC population with markers of the 
oligodendrocyte lineage in ten regions of the mouse CNS. A) Illustration of dissection scheme for the ten CNS regions 
analysed by single cell RNA-Seq. B) Table enumerating the number of cells analysed (after exclusion) for each CNS region. 
C) Dendrogram of OL populations as reconstructed by linkage clustering (left panel). Heatmap described the correlation 
between each pair of clusters (middle panel). Abundance of each of the subclasses along the different CNS regions is 
represented by the area of the circles (right panel). (Adapted from Marques et al., 2016). 
 
 
 
     
 
Figure 5. Model of oligodendrocyte lineage progression from precursors to mature cells. A) t-Distributed stochastic 
neighbor embedding projection displaying the trajectory from OPCs to mature OLs. B) Oligodendrocyte maturation process 
is sequential, continuous and uniform along CNS until the myelin-forming stage, while mature populations show 
heterogeneity and region specificity. MOL1-4 are more common in the juvenile mouse, while MOL5/6 can be found mostly 
in the adult mouse. (Adapted from Marques et al., 2016). 
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The oligodendrocyte lineage arises from OPCs, which express the cell-marker Pdgfra. Differentiation-
committed oligodendrocyte precursors (COPs) are distinct from OPCs because they lack the 
expression of Pdgfra, as all subpopulations from here on, and express genes involved in maintaining 
an OL undifferentiated state. COPs also express migratory genes and low levels of cell cycle markers. 
Newly formed oligodendrocytes (NFOL1 and 2) express genes that induce differentiation, and are 
followed by myelin-forming oligodendrocytes (MFOL1 and 2), which express genes responsible for 
myelin formation. Finally, mature oligodendrocytes (MOL1-6) express late oligodendrocyte 
differentiation genes and genes present in myelinating cells. A second Pdgfra+ population was 
identified, namely vascular and leptomeningeal cells (VLMCs), which are distinct from OPCs and the 
rest of OL lineage. Moreover, VLMCs exhibit markers from the pericyte lineage and are present in 
blood vessels and meninges. The existence of these distinctive OPC and OL states suggests possible 
functional heterogeneity (Marques et al., 2016).  
  
 
Exploring oligodendrocyte lineage heterogeneity and developmental origin 
 
The integration of bulk transcriptomics and single-cell RNA-seq data provide rigorous data sets 
describing the transcriptional OPC and OL heterogeneity from different areas of the CNS and at 
different developmental stages. From these data sets, the host lab short-listed genes that are potentially 
important in defining the functional heterogeneity of OPCs in different areas of the CNS. Seven of the 
short-listed genes are transcription factors or regulators, involved in cell fate specification, 
differentiation, migration, or maintenance of the progenitor state, but that have not been associated 
with the regulation of OPC cell state (Marques et al., 2016). 
 
To assess the specificity and validate these markers in brain and spinal cord sections, antibodies and 
RNA probes were tested through immunohistochemistry (IHC) and RNAscope in situ hybridization 
(ISH), respectively. Genes specifically expressed by the identified 12 OL subpopulations were 
selected and antibodies raised against their encoded proteins were acquired. Those antibodies were 
tested through IHC firstly on non-experimental mice for protocol optimization, followed by the 
application of those protocols on experimental (PdgfraCreER-RCE) juvenile (P20 – 20 days old) and 
adult mice (P60 – 60 days old). Additionally, the detection of co-expression of the mRNAs and 
proteins labeled by the antibodies was intended, as indeed the putative cell markers were selected 
based on mRNA data.  However, mRNAs and proteins can have differential temporal patterns, an 
issue tackled by combining and assessing fluorescent ISH with IHC on brain and spinal cord sections 
from juvenile and adult experimental mice. 
 
Moreover, it was hypothesized that cortical and spinal cord OPCs have a distinct differentiation 
potential, as the percentage of the 12 OL subpopulations is differentially represented in these two 
regions of the CNS. Also, as the proliferation waves of OPCs occur in three different time points, the 
developmental origin of the distinctive OL subpopulations was also investigated both in the brain and 
spinal cord. This subject was addressed by conducting lineage-tracing experiments using the 
tamoxifen-inducible PdgfraCreER-RCE mouse line, selectively expressing GFP (green fluorescent 
protein) reporter in OPCs and their progeny. Recombination of the reporter gene was induced either 
on E12.5 (embryonic day E12.5) or P3-5 (postnatal days 3-5), in order to respectively target the first 
embryonic and postnatal waves of OPC proliferation and their progeny. Subsequently, brain and spinal 
cord were collected at different ages (P20 and P60), and IHC and ISH assays were performed to test 
the putative markers for different subpopulations of OL lineage. 
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Previously unpublished data together with published reports support the hypothesis that the 
oligodendrocyte lineage might display functional heterogeneity and distinct subpopulations might be 
differentially originated from developmental waves. The present work focuses on these issues and, 
therefore, we aimed at: 
 
1. Validation of antibodies and RNA probes for detection of putative cell markers through 
immunohistochemistry and fluorescent in situ hybridization (RNAscope); 
 
2. Determination of the developmental origin of distinct oligodendrocyte subpopulations in the 
juvenile and adult mice 
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Materials and methods 
 
Animals 
All experimental procedures performed followed the guidelines and recommendations of local animal 
protection legislation and were approved by the local committee for ethical experiments on laboratory 
animals (Stockholms Norra Djurförsöksetiska, Sweden). Tamoxifen inducible Pdgfra-CreER/RCE 
mice with a C57BL/6 genetic background are a strain expressing Cre recombinase under the control of 
a Pdgfra genomic promoter. Moreover, this strain has a loxP-flanked STOP cassette and a downstream 
GFP reporter gene, both under the control of a ubiquitous ROSA26 locus. When tamoxifen is 
administered it activates Cre recombinase, which will recognize both loxP sites and excise the STOP 
sequence, allowing the transcription of the GFP gene in Pdgfra+ cells. This Cre-Lox system enables 
the labelling of OPCs and their progeny in recombinant mice. In order to obtain this mouse line within 
one generation, B6N.Cg-Tg (Pdgfra-CreERT)467Dbe/J (Jackson Laboratories, CA, USA), also 
referred to as Pdgfra-CreER mice, were crossed with the reporter mice line Gt(ROSA)26Sortm1.1(CAG-
EGFP)Fsh/Mmjax (Jackson Laboratories, CA, USA), also referred to as RCE:loxP-GFP. Pdgfra-CreER 
(non-inducible Cre) mice were also used for optimization of immunohistochemistry and fluorescent in 
situ hybridization protocols.  
 
 
Genotyping 
Experimental mice carrying both Pdgfra-CreER and RCE:loxP-GFP constructs were identified 
visually by GFP fluorescence under a UV light source between birth (P0) and the third postnatal day 
(P3). The full genotypes were confirmed by PCR using the following primers: Pdgfra-CreER (forward 
– 5’ TCA GCC TTA AGC TGG GAC AT 3’; reverse – 5’ ATG TTT AGC TGG CCC AAA TG 3’), 
RCE (mutant – 5’ CCA GGC GGG CCA TTT ACC GTA AG 3’; common – 5’ AAA GTC GCT CTG 
AGT TGT TAT 3’; wild type – 5’ GGA GCG GGA GAA ATG GAT ATG 3’), GFP (mutant forward 
– 5’ GAT CAC TCA CGG CAT GGA C 3’; mutant reverse – 5’ CGG GCC TCT TCG CTA TTA C 
3’; wild type forward – 5’ AAG GGA GCT GCA GTG GAG TA 3’; wild type reverse – 5’ GAG 
CGG GAG AAA TGG ATA TG 3’). PCR protocols were performed according to Jackson 
Laboratories instructions (Table 1). 
 
PCR mix (volumes for 1 reaction):  
1) 12,5 µl Dream Taq Mastermix (2x, Thermo Scientific) 
2) 0,6 µl primer forward (from 10 µM stock, 0,25 µM final concentration) 
3) 0,6 µl primer reverse (from 10 µM stock, 0,25 µM final concentration) 
4) H2O (total volume of 24 µl) 
5) 0,5-1 µl DNA template 
 
Step Temperature Time 
Denaturation 94oC 1 min 
Amplification (35 cycles) 
94 oC 
58 oC 
72 oC 
45 sec 
45 sec 
1 min 
Elongation 72 oC 5 min 
Hold 10 oC  
 
Table 1. PCR conditions for genotyping 
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Lineage tracing  
For Cre-Lox recombination at E12.5, experimental female mice were given 1mg tamoxifen (10mg/ml 
in corn oil) intraperitoneal injections at pregnancy day 12.5, GFP-labelling the first wave of OPC 
proliferation and their progeny. For Cre-Lox recombination at P3-5, experimental progenitor female 
mice were given daily 2mg tamoxifen (20mg/ml in corn oil) intraperitoneal injections after the litter 
was delivered, from day 3 to 5, GFP-labelling the third wave of OPC proliferation and their progeny. 
 
 
Tissue preparation 
After inducing recombination, experimental mice at post-natal day 20 or 60 were anesthetized with a 
ketamine/xylazine mixture (up to 80 mg/kg body weight ketamine and 10 mg/kg body weight 
xylazine) via intraperitoneal injection. Animals were tested for unresponsiveness through toe-pinch 
method. They were then perfused intracardially with PBS followed by PFA (paraformaldehyde) 4%. 
Brain and spinal cord were dissected and transferred to 4% PFA and incubated overnight at 4ºC. The 
tissue was then rinsed with PBS and maintained in 30% sucrose/ 0.1M PBS overnight at 4ºC, it was 
then stored at -80ºC. For cryosectioning, experimental tissue was embedded in optimal cutting 
temperature (OCT) compound, placed in a cryostat, coronal sections of 14-16µm thickness were 
collected on glass slides and stored at -80ºC. 
 
 
Immunostaining 
Oligodendrocyte subpopulations’ developmental origin and distribution were analysed by using 
specific antibodies for putative cell markers (Table 2). This task was performed through two distinct 
immunohistochemistry protocols. 
 
Standard protocol 
Tissue sections were thawed for 15 min, washed in PBS-0.05% Tween-20 (PBS-T) for 10 min, treated 
with blocking solution (5-10% donkey serum, 0.3% Triton X-100 in PBS-T) for 1 h and then 
incubated overnight with primary antibody diluted in 2-3% donkey serum solution. Tissue sections 
were then washed three times in PBS-T (10 min per wash), treated with secondary antibody Alexa 
Fluor-conjugated diluted in 2-3% donkey serum solution for 1 h, washed again three times in PBS-T 
(10 min per wash), incubated with DAPI (nuclear counterstain) for 1-2 min and washed once again for 
10 min in PBS-T. Slides were coverslipped in mounting medium (Dako) and stored in a cold room 
(~4ºC) until further microscopic analysis. All steps were performed at room temperature (20-25ºC).  
 
Streptavidin enhancement protocol 
Tissue sections were thawed for 15 min, washed in PBS-0.05% Tween-20 (PBS-T) for 10 min, treated 
with blocking solution (5-10% donkey serum, 0.3% Triton X-100 in PBS-T) for 1 h and then 
incubated overnight with primary antibody diluted in 2-3% donkey serum solution. Tissue sections 
were then washed three times in PBS-T (10 min per wash), treated with biotinylated secondary 
antibody diluted in 2-3% donkey serum solution for 1 h, washed again three times in PBS-T (10 min 
per wash), incubated with streptavidin Alexa Fluor-conjugated diluted in 2-3% donkey serum solution 
for 1 h, washed again three times in PBS-T (10 min per wash), incubated with DAPI (nuclear 
counterstain) for 1-2 min and washed once again for 10 min in PBS-T. Slides were coverslipped in 
mounting medium (Dako) and stored in a cold room (~4ºC) until further microscopic analysis. All 
steps were performed at room temperature (20-25ºC). 
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Antibody Host Dilution for IHC Source 
GFP (Green fluorescent protein) Chicken 1:500  (IHC and ISH) Abcam 
Egr2 (Early growth response 2) Rabbit 1:200 Abcam 
FosB (FBJ osteosarcoma oncogene B) Rabbit 1:500 Abcam 
HOPX (Homeodomain only protein) Rabbit 1:100 Abcam 
Ptgds (Prostaglandin D2 synthase) Rabbit 1:50 Abcam 
Alexa Fluor 488-conjugated antibody to chicken IgG  Donkey 1:500  (IHC and ISH) Invitrogen 
Alexa Fluor 568-conjugated antibody to rabbit IgG Donkey 1:500 Invitrogen 
Alexa Fluor 647-conjugated antibody to rabbit IgG Donkey 1:500 Invitrogen 
Byotinilated antibody to rabbit IgG Donkey 1:500 Invitrogen 
Streptavidin Alexa Fluor 568-conjugated Donkey 1:500 Invitrogen 
 
Table 2. Antibody sources and concentrations 
 
 
Immunostaining coupled with RNAscope 
RNAscope fluorescent in situ hybridization (ISH) assay was coupled with immunohistochemistry for 
identification of single RNA transcripts and target proteins. Tissue sections were thawed for 15 min, 
placed in a hot plate (100ºC) while 1x target retrieval at 98-100ºC was continuously added for 5 min. 
Sections were transferred to a staining dish containing distilled water (RNAse free) and washed twice 
for 2 min, followed by a 2 min wash of EtOH 100%. Protease IV was applied to the sections for 20 
min at room temperature (20-25ºC), which were posteriorly transferred to a dish containing distilled 
water (RNAse free) and washed twice for 2 min. RNAscope Multiplex Fluorescent Assay v2 
(Advanced Cell Diagnostic) assay followed, consisting on cycles of hybridization of the target probe, 
signal amplification and HRP (horse radish peroxidase) signal development, according to the 
manufacturer’s protocol instructions. Standard immunohistochemistry protocol was then performed. 
The probes used in these studies were against Egr2, HOPX, Ptgds, Ptprz1 (Protein tyrosine 
phosphatase receptor type Z) and Sox10 (stock concentrations from kit). The primary antibody used in 
these studies was against GFP. Secondary antibody was Alexa Fluor 488-conjugated donkey antibody 
to chicken IgG. 
 
 
Image acquisition and analysis 
Representative images with a combination of DAPI, GFP (Alexa 488), Alexa 555 and/or Alexa 647 
staining were obtained in a Zeiss LSM800 Confocal with ZEN software interface. The regions of 
interest in the brain were the somatosensory cortex and corpus callosum, while in the spinal cord were 
the dorsal horn and corticospinal tract. The tissue was photographed by performing a Z-stack of 5-14 
stacks per image, representing 3-7 µm of tissue depth, with a 40x objective. 
Images for quantification were photographed by performing a Z-stack of 2-4 stacks per image, 
representing 1.5-3 µm of tissue depth, with a 20x objective. A tiling method was also performed, with 
the number of acquired tiles depending on the region of interest (corpus callosum – 3 tiles; cortex, 
dorsal horn and corticospinal tract – 4 tiles each). For each time-point (P20 or P60) 3 animals were 
used and 3 tissue sections were photographed per animal. The cell counting was normalized to the area 
analysed in each photo (CellProfiler). 
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Results 
 
Validation of antibodies against cell markers for oligodendrocyte lineage in the juvenile mouse 
 
For the detection of mature oligodendrocytes 1 (MOL1) subpopulation in the brain and spinal cord of 
the mouse, we assessed an antibody against Egr2. We targeted the postnatal wave of OPCs (Pdgfra+) 
and their progeny by conducting lineage-tracing experiments and identifying these cells as GFP+. To 
achieve this, experimental mice (PdgfraCreER-RCE) were recombined on postnatal day 3 to 5 (P3-5) 
and tissue was collected on postnatal day 20 (P20), followed by a standard immunohistochemistry 
protocol. The antibody used for the detection of GFP is reliable, consistently displaying a strong and 
clear signal localized within the cells throughout all the experiments presented in this work. 
Contrarily, Egr2 expression pattern lacks specificity, displaying a broad background signal without 
overlap between GFP+ cells in the cortex, corpus callosum and corticospinal tract. Nevertheless, it is 
possible to detect the outline of some Egr2+ cells in the dorsal horn appearing to colocalize with GFP+ 
cells, although given the unspecific signal in the remaining analysed areas it is not possible to be 
completely certain (Supplementary fig. 1). Negative controls, with the omission of the primary 
antibody, were performed and assessed visually throughout all IHC experiments in this work (images 
not shown). Thus, a negative control for Egr2 was analysed, in which unspecific background 
fluorescence was absent (images not shown). Additionally, we performed a staining in the same areas 
of mice recombined on P3-5 and collected the tissue on P60, and Egr2 fluorescent signal was absent 
both in the brain and spinal cord (images not shown). As potential MOL1 were detected in the dorsal 
horn, the protocol for this antibody requires further optimization, in order to improve the fluorescent 
signal in the remaining areas. 
 
Since the detection of MOL1 could not be fully accomplished by using the antibody against Egr2, we 
targeted FosB, another marker for this OL subpopulation. This marker is also present in vascular and 
leptomeningeal cells (VLMC), as indicated by single-cell RNA-seq, and consequently the antibody 
against FosB detects both subpopulations. VLMCs are described as a secondary Pdgfra+ 
subpopulation, alongside OPCs, being also labelled by the GFP antibody. To test this antibody we 
recombined experimental mice on P3-5, targeting the postnatal wave of OPC and progeny (GFP+ 
cells), and collected brain and spinal cord on P20, followed by a standard immunohistochemistry 
procedure. FosB+ cells present a clear staining, with the signal distributed within the cell nuclei, in the 
cortex, dorsal horn and corticospinal tract (Supplementary fig. 2). Contrarily, the signal of FosB+ 
cells in the corpus callosum was non-existent. The negative control did not show any fluorescent 
signal. Double positive FosB/GFP cells presence is displayed in the cortex and dorsal horn while it is 
absent in the corticospinal tract, where a smaller number of FosB+ cells was detected. Therefore, a 
number of cells generated from the postnatal wave of proliferation are present in the juvenile mouse as 
FosB+ cells, requiring further identification as either MOL1 or VLMC.  
 
In order to detect mature oligodendrocytes 2 (MOL2) subpopulation in the CNS of the mouse, we 
tested an antibody against HOPX. In this lineage tracing experiment we recombined experimental 
mice on P3-5, in order to target the postnatal wave of OPC and their progeny (GFP+ cells), collected 
tissue on P20 and performed a standard immunohistochemistry protocol. HOPX+ cells display a strong 
signal, which seems to be present mostly around the nuclei. The staining puts the cells in evidence 
even though there is a certain degree of background fluorescent signal, which was not detected in the 
negative control (images not shown). Moreover, there is colocalization between GFP+ cells and 
HOPX+ cells, both in the brain and spinal cord (Fig. 6). This shows that a number of MOL2 are 
originated from OPCs that proliferate from the postnatal wave and are present in the juvenile mouse. 
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We performed an additional staining in mice recombined on P3-5, whose tissue was collected on P60, 
and we did not detect any HOPX+ cells (images not shown). Thus, based on its relatively clear and 
strong signal and overlap with GFP+ cells, HOPX is a potentially reliable antibody for the 
identification and lineage tracing of MOL2 in the juvenile mouse. 
                                  
  
 
 
Figure 6. HOPX+ cells colocalize with GFP+ cells originated from the postnatal developmental wave in the juvenile 
mouse. Immunohistochemistry targeting MOL2 (HOPX) and Pdgfra+ cells and progeny (GFP) in cortex (A), corpus 
callosum (B), dorsal horn (C) and corticospinal tract (D). Experimental mice were recombined on P3-5 and tissue was 
collected on P20. Yellow arrows indicate signal colocalization between HOPX+ cells and GFP+ cells. Scale bars represent 
50µm. 
 
 
Validation of RNA probes against cell markers for oligodendrocyte lineage in the juvenile mouse 
 
Following these results, we performed a fluorescent staining in situ hybridization coupled with 
immunohistochemistry, labelling single RNA molecules and proteins, respectively. Here we used an 
Egr2 RNA probe to identify MOL1, and the regular GFP antibody, thereby assessing the 
colocalization of signal within cells. Negative controls for probes were performed, according to 
instructions of the manufacturer, and assessed visually throughout all ISH coupled with IHC 
experiments in this work (images not shown).  In order to target the postnatal developmental wave, 
experimental mice were recombined on P3-5 and the tissue was collected on P20. Egr2 probe displays 
a scattered fluorescent signal and the RNA molecules are localized in the cell body and cellular 
processes. There is colocalization between GFP+ cells and Egr2 RNA in all analysed areas 
(Supplementary fig. 3), though quantification is challenging since the signal of the probe is too 
dispersed. Nevertheless, this experiment shows that a number of MOL1 are originated from the 
postnatal wave of OPC proliferation and are present in the analysed areas of the CNS in the juvenile 
mouse. Moreover, we performed a similar experiment targeting MOL2 by using a RNA probe for 
HOPX, aiming to establish a comparison with the expression pattern of the HOPX antibody. However, 
A B 
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while the probe was effective and displayed a clear signal, GFP labelling presented some issues, most 
likely due to deficient blocking, displaying a fluorescence pattern that did not allow the proper 
identification of OPCs and progeny (images not shown). 
 
 
Validation of antibodies against cell markers for oligodendrocyte lineage in the adult mouse 
 
For the detection of mature oligodendrocytes 5 and 6 (MOL5/6) in the adult mouse we assessed an 
antibody against Ptgds. Experimental mice were recombined on P3-5 for lineage tracing, targeting the 
postnatal wave of OPCs and their progeny and the tissue was collected on P60. Here we firstly used a 
standard immunohistochemistry protocol, which proved to be non-efficient, since the Ptgds antibody 
signal was too faint (images not shown). Consequently, we enhanced the fluorescent signal of the 
antibody by using a streptavidin system, which gave a considerably clearer image of the expression 
pattern. Ptgds+ cells display a strong signal, distributed within the cell body and cellular processes, as 
well as a degree of colocalization with GFP+ cells in the analysed areas of the brain and spinal cord 
(Fig. 7). This demonstrates that a number of MOL5/6 are originated from the postnatal wave of 
proliferation, being present in the cortex, corpus callosum, dorsal horn and corticospinal tract in the 
adult mouse.  
 
 
   
   
 
Figure 7. Ptgds+ cells colocalize with GFP+ cells originated from the postnatal developmental wave in the adult mouse. 
Immunohistochemistry targeting MOL5 and 6 (Ptgds) and Pdgfra+ cells and progeny (GFP) in cortex (A), corpus callosum 
(B), dorsal horn (C) and corticospinal tract (D). Experimental mice were recombined on P3-5 and tissue was collected on 
P60. Yellow arrows indicate signal colocalization between Ptgds+ cells and GFP+ cells. Scale bars represent 50µm.  
A B 
C D 
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Validation of RNA probes against cell markers for oligodendrocyte lineage in the adult mouse 
 
Following these results, we performed fluorescent staining coupling in situ hybridization and 
immunohistochemistry, labelling RNA molecules and proteins, respectively. To do this we used a 
Ptgds RNA probe and the mentioned Ptgds antibody, assessing signal colocalization within cells, as to 
validate the antibody efficiency for the detection of MOL5/6. Here, as in the previous experiment, we 
recombined experimental mice on P3-5, targeting the postnatal wave of OPC and their progeny and 
collected the tissue on P60. Fluorescent imaging showed that both probe and antibody signal is clear 
and located within the cell body. However, while colocalization was evidenced in the corpus callosum, 
it was absent in the cortex and dorsal horn (images of corticospinal tract not acquired) 
(Supplementary fig. 4). Additionally, a larger number of cells were labelled by the antibody, in 
comparison to those identified by the probe. We proceeded with experiments for validation of 
subpopulation-specific cell markers by using RNA probes, since these results are a closer approach to 
the initial data acquired through single-cell RNA-seq due to the assessment of similar molecules by 
both techniques. 
 
We performed another in situ hybridization coupled with immunohistochemistry, labelling Ptgds RNA 
molecules and GFP. Here we used two sets of mice, recombined either on E12.5 or P3-5 for lineage 
tracing, respectively targeting the embryonic and postnatal developmental waves, and collected the 
tissue on P60. In order to make a time-wise efficient analysis, we imaged cortex, corpus callosum and 
dorsal horn under both recombination conditions, dismissing the corticospinal tract. As established in 
the previous experiment, the fluorescent signal of the probe is clear and distributed within the cell 
body. Moreover, colocalization between Ptgds+ cells and GFP+ cells is seen in all analysed areas from 
mice recombined on both time-points (Fig. 8A-F). This demonstrates that a number of MOL5/6 are 
originated from the first embryonic wave of OPC proliferation, while others differentiate from the 
postnatal wave and cells from both origins are present in the adult mouse.  
 
To better assess the percentage of MOL5/6 that are originated from each wave of OPC proliferation, 
we performed image quantification (Fig. 8G).  In the cortex, the percentage of cells originated from 
the first embryonic wave that become MOL5/6 is ~20%, while ~40% of cells originated from the 
postnatal wave differentiate into these subpopulations. Both waves similarly originate MOL5/6 in the 
corpus callosum, which accounts for ~80% of lineage traced cells from each wave of proliferation. 
The percentage of lineage traced MOL5/6 in the dorsal horn originated from the embryonic wave 
accounts for ~30%, while ~50% of the cells that derive from the postnatal wave give rise to MOL5/6. 
Thus, in the corpus callosum the majority of cells originated from the embryonic and postnatal 
developmental waves give rise to MOL5/6 in the adult mouse. Moreover, the differentiation potential 
is balanced between both waves, as each of them originates a similar percentage of MOL5/6. In 
contrast, in the cortex and dorsal horn a lesser percentage of cells differentiate into MOL5/6, where 
the postnatal wave originates a higher percentage of MOL5/6 in comparison with the embryonic wave. 
Additionally, we quantified the percentage of MOL5/6 out of all cells present in the analysed areas of 
the mature mouse (Supplementary fig. 5). These subpopulation constitute ~10% of the cells in the 
cortex, ~50% in the corpus callosum and ~20% in the dorsal horn. 
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Figure 8. Ptgds+ cells colocalize with GFP+ cells originated from the embryonic and postnatal developmental waves in 
the adult mouse RNAscope in situ hybridization combined with standard immunohistochemistry targeting MOL5 and 6 
(Ptgds - probe) and Pdgfra+ cells and progeny (GFP - antibody) in cortex (A, B), corpus callosum (C, D) dorsal horn (E, F). 
Experimental mice were recombined on E12.5 (A, C, E) and P3-5 (B, D, F) and tissue was collected on P60. Yellow arrows 
indicate signal colocalization between Ptgds RNA molecules and GFP+ cells. Scale bars represent 50µm. Percentage of fate 
mapped MOL5/6 originated from the embryonic and postnatal developmental waves (G). Data reported as mean ± standard 
error of the mean (SEM), n=3. 
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Validation of RNA probes against cell markers for OPCs and COP in the adult mouse 
 
Ptprz1 is a cell marker for OPCs and differentiation-committed oligodendrocyte precursors (COP), as 
evidenced by single-cell RNA-seq. We analysed the level of colocalization between Ptprz1+ cells and 
GFP+ cells, and the percentage of OPCs and COP that derive from the embryonic and postnatal waves. 
For lineage tracing, mice were recombined either on E12.5 or P3-5, targeting the embryonic and 
postnatal waves of proliferation, and tissue was collected on P60. We performed in situ hybridization 
coupled with immunohistochemistry, labelling Ptprz1 RNA molecules and GFP. The fluorescent 
signal of the probe displayed a scattered pattern, distributed in the cell body and cellular processes. 
Colocalization between Ptprz1+ cells and GFP+ cells can be seen in all analysed regions, namely 
cortex, corpus callosum and dorsal horn, in both recombination conditions (Fig. 9A-F). These results 
demonstrate that OPCs and COP are present in the adult mouse and result from both developmental 
waves. 
 
In order to evaluate the percentage of OPCs and COP that arise from each wave of proliferation, we 
performed image quantification (Fig. 9G). In the cortex, both waves seem to contribute for the 
proliferation and differentiation of OPCs and COP by ~10% each. A similar result was gathered in the 
corpus callosum, where the amount of cells that derive from each wave is ~10% of OPCs and COP. In 
the dorsal horn, ~30% of cells from the first wave are OPCs and COP, while less than 10% of those 
that derive from the postnatal wave are OPCs and COP. Thus, in the adult mouse a larger percentage 
of cells derived from the first embryonic wave are maintained as OPCs and COP, in comparison to the 
postnatal wave, in the dorsal horn. By contrast, in the cortex and corpus callosum both developmental 
waves contribute equally for the presence of OPCs and COP. Moreover, the percentage of OPCs and 
COP out of all cells present in the analysed areas of the mature mouse was quantified 
(Supplementary fig. 5). OPCs and COP constitute ~10% of the cells in the cortex, ~30% in the 
corpus callosum and ~30% in the dorsal horn. 
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Figure 9. Ptprz1+ cells colocalize with GFP+ cells originated from the embryonic and postnatal developmental waves in 
the adult mouse. RNAscope in situ hybridization combined with standard immunohistochemistry targeting OPCs and COP 
(Ptprz1 - probe) and Pdgfra+ cells and progeny (GFP - antibody) in cortex (A, B), corpus callosum (C, D) dorsal horn (E, F). 
Experimental mice were recombined on E12.5 (A, C, E) and P3-5 (B, D, F) and tissue was collected on P60. Yellow arrows 
indicate signal colocalization between Ptprz1 RNA molecules and GFP+ cells. Scale bars represent 50µm. Percentage of fate 
mapped OPCs and COP originated from the embryonic and postnatal developmental waves (G). Data reported as mean ± 
standard error of the mean (SEM), n=3. 
A 
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Postnatal developmental wave originates the predominant population of OPCs and progeny in 
the adult mouse  
 
As a final experiment we performed a triple staining targeting MOL5/6 (Ptgds), fate-mapped 
embryonic and postnatal waves of OPC and progeny (GFP), and OL lineage (Sox10). Sox10 is an 
established marker for detection of OL lineage, which includes OPCs and other OL subpopulations 
altogether. Here we analyse colocalization between double positive cells (Ptgds/Sox10 and 
GFP/Sox10) and triple positive cells (Ptgds/GFP/Sox10). To do this, mice were recombined either on 
E12.5 or P3-5, targeting the embryonic and postnatal developmental waves, and tissue was collected 
on P60. We performed in situ hybridization coupled with immunohistochemistry, targeting Ptgds and 
Sox10 RNA molecules and GFP. The fluorescent signal of Ptgds probe is clear and distributed within 
the cell body, as previously shown, and Sox10 displays a similar expression pattern throughout the 
cortex, corpus callosum and dorsal horn (Fig. 11). Double and triple colocalization between the 
different markers can be seen in all analysed areas, in both recombination conditions. These results 
confirm that Ptgds+ cells (MOL5/6) and GFP+ cells (fate-mapped OPCs and progeny) are also Sox10+ 
and are indeed part of the OL lineage, thereby validating the specificity of the markers used.  
 
Based on these results we performed the quantification analysis in three distinct branches. Firstly, we 
analysed the percentage of MOL5/6 per Sox10+ cells in the imaged areas of the CNS (Fig. 10A). In 
the cortex 50-60% of the OL lineage cells are MOL5/6, while in the corpus callosum they constitute 
~90% and in the dorsal horn ~70%. Following, we analysed the percentage of fate-mapped OPCs and 
progeny originated from the embryonic and postnatal waves per Sox10+ cells (Fig. 10B). In the cortex, 
both waves seem to originate ~60% of the Sox10+ cells. Contrarily, in the corpus callosum and spinal 
cord the embryonic wave seems to originate the least amount of cells, contributing with ~20% on one 
case and 30-40% on the other, while the postnatal wave gives rise to ~50% and ~40% of cells, 
respectively. Lastly, the percentage of OLs per total number of cells in the analysed areas was also 
quantified (Fig. 10C). Out of all cells in the corpus callosum ~50% belong to the OL lineage, with the 
postnatal developmental wave being the main contributor. Dorsal horn follows, with ~25% of its cells 
being OPCs or OLs and both the embryonic and postnatal waves contributing equally for the their 
presence. The cortex is the analysed area with the smallest percentage of OL lineage cells, accounting 
for ~15% of cells present in this area, where the postnatal wave originates a slightly higher number of 
cells in comparison with the embryonic wave. 
 
                                           
   
             
 
A B 
C Figure 10. Percentage of oligodendrocytes present 
in the adult mouse. A) Percentage of fate mapped 
MOL5/6 per Sox10+ cells. B) Percentage of fate-
mapped OLs per Sox10+ cells derived from the 
embryonic and postnatal developmental waves. C) 
Percentage of OLs per total number of cells in the 
adult CNS. Analysed areas were cortex, corpus 
callosum and dorsal horn. Data reported as mean ± 
standard error of the mean (SEM), n=3. 
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Figure 11. Positive Ptgds/GFP/Sox10 cells are originated from the first embryonic and postnatal developmental waves 
and are present in the adult mouse. RNAscope in situ hybridization combined with standard immunohistochemistry 
targeting MOL5 and 6 (Ptgds - probe), OL lineage (Sox10 - probe) and Pdgfra+ cells and progeny (GFP - antibody) in cortex 
(A, B), corpus callosum (C, D) and dorsal horn (E, F). Experimental mice were recombined on E12.5 (A, C, E) and P3-5 (B, 
D, F) and tissue was collected on P60. Merge images display Ptgds, GFP, Sox10 and DAPI. Yellow arrows indicate signal 
colocalization between Ptgds and Sox10 RNA molecules and GFP+ cells. Scale bars represent 50µm. 
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Discussion 
 
In this work we performed immunohistochemistry (IHC) and in situ hybridization (ISH) assays by 
using antibodies and probes specific for cell markers of subpopulations from OL lineage in order to 
identify them in areas of the CNS of the juvenile (P20) and adult mice (P60). Moreover, we assessed 
the developmental origin of OPCs and progeny by performing lineage-tracing experiments. Since the 
existence of transcriptional heterogeneity in OL lineage was recently unveiled by single-cell RNA-seq 
data, most antibodies and probes used in this study represent a novelty for the identification of OL 
subpopulations. By performing IHC assays targeting putative cell-markers of OL lineage in juvenile 
and adult mice tissue sections, a number of antibodies display potentially specific fluorescent signal. 
The results obtained by using these antibodies present evidence about the distribution and 
developmental origin of OL subpopulations. Protocol optimization was performed in the cases where 
antibody fluorescent signal was not as strong and clear as desirable. This enabled the improvement of 
signal in some cases, while in others this was not possible. Nevertheless, the antibodies shown here 
require further validation as to confirm their specificity, which can be verified through several ways.    
 
In general, antibodies can perform well in a given context and inadequately in other due to differences 
in protein conformation and target accessibility, for instance (Bordeaux et al., 2010). A highly specific 
antibody recognizes its target with minimal off-target binding (cross-reactivity). However, this is not 
always the case, and IHC results often present issues regarding the confirmation of the efficiency of 
antibodies, which can be tackled by several methods. Genetic strategies assess antibody specificity by 
measuring signal in control cells or tissue in which the target gene or epitope has been knocked out or 
knocked down. Thus, the expression of the target protein is eliminated or dramatically decreased, and 
the presence of signal indicates cross-reactivity. Another approach consists on using two or more 
independent antibodies that recognize different regions of the target protein. If the expression pattern 
generated by the antibodies is correlated it means they are binding to distinct epitopes of the same 
protein, minimizing the probability of cross-reactivity. Antibodies can also be validated by expressing 
a protein that contains a reporter, such as GFP or an affinity tag. This allows the detection of 
colocalization between antibody and reporter signals, thereby validating the specificity of the 
antibody. An additional method is adsorption, in which the antigen is pre-incubated with the antibody 
preceding the assay. Though it shows target binding, this approach will not exclude cross-reactivity 
with proteins that possess similar epitopes as the intended target (Howat et al., 2014; Uhlen et al., 
2016). Therefore, at least one of these methods should be used in order to claim that a given antibody 
has been validated, and the use of more than one strategy strengthens its reliability.  
 
Complementing IHC studies in the mouse, we used RNAscope ISH to identify different OL 
subpopulations in the CNS. This novel technique enables single-molecule visualization in individual 
cells by using an amplification system associated with the probe. By enhancing the signal without 
amplifying the background, this method improves both sensitivity and specificity in comparison to 
regular RNA ISH. This technique is a closer association with the single-cell RNA-seq data, from 
which OL lineage markers were identified, since it also evaluates the presence of RNA molecules in 
the cells. Moreover, RNAscope adds information about spatial distribution of molecules within the 
cells and localization of cells that incorporate fluorescent signal in different tissue areas (Wang et al., 
2012). An important notion to retain in this work is that mRNA levels do not always correlate with the 
corresponding protein levels in a given cell-type, as this correlation depends on several biological 
factors. Here we analysed cell-types that undergo dynamic differentiation processes and compared the 
presence of both molecules. Therefore, the delay between transcription and translation should be taken 
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into consideration, as well as post-transcriptional processes that might lead to greater deviations from 
an ideal correlation (Edfors et al., 2016; Liu et al., 2016).  
 
For the detection of MOL1 we performed immunohistochemistry, using an antibody against Egr2 
(Early growth response 2), which is a sequence-specific DNA-binding transcription factor present 
mostly in the nucleus. It is described as a regulator of a diverse array of genes required for peripheral 
nerve myelination (Jang et al., 2006). Egr2 antibody displayed a fluorescent signal widely distributed 
in the tissue of the juvenile mouse and apparently unspecific, since the outline of Egr2+ cells could 
only be dimly detected in the dorsal horn. In this area of the spinal cord, some Egr2+ cells also appear 
to colocalize with GFP+ cells, thus potentially being MOL1. A negative control was performed and, 
therefore, this signal is not due to unspecific binding of the secondary antibody. Consequently, there 
are several possible reasons why the antibody did not display the desired fluorescent signal. Since the 
background fluorescence is very strong, the primary antibody might be binding unspecifically to other 
molecules. A way to counter this would be to increase the concentration of the blocking solution, for 
instance, thereby reducing cross-reactivity. Also, since there are Egr2 labelled cells that appear to 
colocalize with GFP+ cells in the dorsal horn, lowering the concentration of the primary antibody 
might decrease the background fluorescence and put in evidence Egr2+ cells in the remaining areas. 
Additionally, ISH coupled with IHC displayed the presence of Egr2 mRNA molecules within GFP+ 
cells, specifically in the cellular bodies and processes, not only in the dorsal horn, as the antibody, but 
in the other analysed areas as well. These results suggest that the levels of mRNA and protein do not 
correlate or that probably exists a temporal mismatch between their expression in the cell (Edfors et 
al., 2016). Since the antibody did not display signal in experimental P60 brain and spinal cord, the 
presence of Egr2 mRNA should be tested with ISH, as to detect the eventual presence of MOL1 in the 
adult mouse. As stated by Marques et al., some mature oligodendrocyte subpopulations might be 
present only during the juvenile state and disappear as the organism further develops. Thus, the 
absence of antibody signal in the tissue of adult mouse might indeed suggest the absence of MOL1.  
 
Furthermore, we used an antibody against FosB (FBJ osteosarcoma oncogene B), a marker for both 
MOL1 and VLMCs, described as a transcription factor that interacts with Jun proteins and enhances 
their DNA-binding activity, playing a role in cell proliferation and differentiation (Gruda et al., 1996). 
FosB antibody exhibited a clear signal distributed within the cell nuclei, in the cortex, dorsal horn and 
corticospinal tract. While a number of FosB+ cells colocalize with GFP+ cells present in the cortex and 
dorsal horn, double positive cells are absent in the corticospinal tract. Even though MOL1 and 
VLMCs are morphologically distinct, it is not possible to distinguish them simply by labelling with 
FosB. As VLMCs and OPCs that will give rise to the remaining OL lineage both are Pdgfra+, they also 
cannot be told apart by GFP antibody. Thus, a way to tackle this problem would be to use another 
antibody specific for VLMCs, such as Col1a1, and image it on a different fluorescent channel of the 
confocal microscope. Subsequently, FosB+/Col1a1+ cells would be VLMCs and FosB+/Col1a1- cells 
would be MOL1. An equivalent result could be achieved by using an antibody against Sox10, a 
marker for the OL lineage, instead of Col1a1. This way, FosB+/Sox10+ cells would be MOL1 and 
FosB+/Sox10- cell would correspond to VLMCs (Marques et al., 2016). Although we did not perform 
the latter experiments, they can be considered in the future if MOL1 or VLMCs are to be imaged 
through immunohistochemistry.  
 
For MOL2 detection, we used an antibody against HOPX (Homeodomain only protein), the smallest 
known member of the homeodomain-containing protein family, which is atypically unable to bind 
DNA. It is involved in the regulation of cell proliferation and differentiation (Mariotto et al., 2016). 
The signal of the antibody is strong and is present mostly around the nuclei, displaying colocalization 
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with GFP+ cells in the brain and spinal cord. Moreover, we tested the antibody in P60 brain and spinal 
cord but did not detect fluorescent signal, which suggests MOL2 might be absent in the adult mouse 
CNS. Therefore, the signal appears to be specific in the juvenile mouse tissue, but the antibody 
requires further validation, which we tried to perform by using a probe specific for HOPX mRNA 
molecules through RNAscope. The probe signal was clear and distributed within the cell bodies, but 
the GFP antibody signal was broadly distributed in an unspecific manner, most likely due to an issue 
with the blocking step. Further experiments should be performed using HOPX antibody and probe in 
juvenile and adult tissue sections, as to validate the antibody specificity and confirm the presence of 
HOPX mRNA in GFP+ cells. Nevertheless, if the antibody is validated it signifies that a number of 
MOL2 are originated from the postnatal developmental wave and are present in the cortex, corpus 
callosum, dorsal horn and corticospinal tract of the juvenile mouse. 
 
In the case of MOL5 and 6, mostly present in the adult mouse, the antibody used for their detection 
was against Ptgds (Prostaglandin D2 synthase). This marker is described as having an anti-apoptotic 
role in oligodendrocytes as well as other maturation and maintenance functions in the CNS (Evans et 
al., 2013). After streptavidin enhancement, the antibody displayed a clear signal, colocalizing with 
postnatal GFP+ cells both in the brain and spinal cord. Additionally, we simultaneously labelled Ptgds 
mRNA molecules and proteins in tissue sections by coupling IHC and RNAscope, respectively. Since 
the initial classification of the 12 OL subpopulations was based on single-cell RNA-seq data, a closer 
association can be achieved through ISH, as this technique assesses the presence of RNA molecules in 
the tissue as well. Therefore, a large amount of cellular colocalization between Ptgds probe and 
antibody would validate the antibody efficiency for the detection of MOL5/6. Nevertheless, 
colocalization was only present in corpus callosum and there was a higher number of cells that 
displayed antibody signal, in comparison to those that shown probe signal. These results suggest the 
existence of temporal disparities between the expression of Ptgds mRNA and protein in the cells. ISH 
coupled with IHC demonstrated that Ptgds probe displays colocalization with a degree of GFP+ cells 
originated from the embryonic and postnatal waves, in the cortex, corpus callosum and dorsal horn. 
Cellular quantification showed that around half of the cells of the corpus callosum of the adult mouse 
are MOL5/6, which is in accordance to previous studies that claim a large number of OLs are located 
in white matter, as these are highly myelinated areas of the CNS (Miller, 2002). Moreover, in the adult 
mouse, most cells originated from the embryonic and postnatal developmental waves develop into 
MOL5/6. On the other hand, grey matter areas display a smaller number of oligodendrocytes, as well 
as lower myelination levels (Dimou et al., 2008). These studies corroborate our results, as a lower 
percentage of cells in the cortex and dorsal horn were identified as MOL5/6. Additionally, in these 
areas a slightly higher percentage of MOL5/6 are originated from the postnatal developmental wave, 
in comparison with the embryonic wave. Cell colocalization analysis between fluorescent signal of 
probes detecting Ptgds mRNA and Sox10 mRNA, which is an established marker for the entire OL 
lineage, demonstrates that MOL5 and 6 are indeed the predominant subpopulations from OL lineage 
(60-90%) in corpus callosum, cortex and dorsal horn. These results correlate with RNA-seq data, 
which point out that MOL5/6 are the most abundant cells from OL lineage in the analysed areas of the 
adult mouse (Marques et al., 2016). Together these results demonstrate that MOL5 and 6 are crucial 
for an efficient axonal myelination, ensuring a proper performance of the CNS in the adult mouse. 
 
Ptprz1 (Protein tyrosine phosphatase receptor type Z) was used for detection of OPCs and COP in the 
brain and spinal cord of the adult mouse. Ptprz1 is a receptor present in the membrane of OL lineage 
cells, crucial in regulation of differentiation and myelin production throughout development and 
during remyelination events (Kuboyama et al., 2015).  Probe signal is distributed in the cell bodies and 
cellular processes, displaying colocalization with GFP+ cells. While most mRNA molecules are 
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translated in the rough endoplasmic reticulum, Ptprz1 mRNA molecules seem to be transported to 
other areas of the cell beforehand, i.e. distal processes. Studies show that some mRNAs contain a 
localization signal and are transported to the cellular processes, such is the case of myelin basic 
protein (MBP) mRNA (Jansen, 2001). In these cases, mRNA molecules are incorporated in transport 
granules and carried along microtubules, only being translated at their destination (Smith, 2004). 
Therefore, this process is most likely involved in the delivery and translation of Ptprz1 in the cellular 
processes, influencing thereby the first phases of axonal contact and myelination. COP present slight 
molecular differences compared to OPCs, as the former lack Pdgfra and express genes involved in 
migration but also others involved in keeping OLs undifferentiated, while they also present low levels 
of cell cycle markers. Therefore COP represents a migratory cell state that will later initiate 
differentiation into other OL subpopulations (Marques et al., 2016).  Cellular quantification showed 
that the corpus callosum and dorsal horn retain a similar amount of OPCs/COP, ~30% of the cells, 
while the cortex displays only ~10%. Therefore, in the brain there is a slightly larger amount of 
OPCs/COP in the white matter, in comparison to grey matter. Since we did not acquire images of the 
white matter in the spinal cord, it is not possible to compare the percentage viewed in the dorsal horn. 
Moreover, the developmental origin of these OL lineage subpopulations is rather balanced in the 
brain, with each wave maintaining ~10% of their cells as OPCs/COP. On the other hand, in the dorsal 
horn the embryonic wave contributes with the major amount of OPCs/COP.  
 
Finally, we used a probe against Sox10, which is a widely used marker for the identification of the 
entire OL lineage, and analysed colocalization with GFP+ cells in the adult mouse. Ptgds probe is 
validated in this experiment, as it colocalizes with Sox10 probe signal and GFP+ cells as well, showing 
MOL5/6 are present in the adult mouse CNS and are originated from the embryonic and postnatal 
waves.  In the corpus callosum, around half of the total number of cells in this area belong to OL 
lineage, with the majority of OLs being originated from the postnatal wave of proliferation. This 
relates to previous studies, as white matter is largely populated by myelinating OLs (Miller, 2002; 
Simons and Nave, 2015). Contrarily, the cortex is populated by a small amount of cells from the OL 
lineage, and their origin is more evenly shared between both developmental waves. Around a quarter 
of the total amount of cells belongs to OL lineage in the dorsal horn, with the cells derived from both 
developmental waves contributing equally for these numbers. These results are also in line with 
preceding studies, as grey matter consists of a lower number of myelinating cells (Hofmann et al., 
2017).  
 
The presence of OPCs in multiple sclerosis (MS) lesions is well established, as they respond in the 
context of demyelination by exhibiting remyelination potential, which has been evidenced by the use 
of animal models such as experimental autoimmune encephalomyelitis (EAE) mice (Goldenberg, 
2012). Therefore understanding OPC origin and response to demyelinating insults is fundamental for 
the development of cell-based therapies. Studies have shown that OPCs respond to molecular cues and 
proliferate towards areas that have been injured, thereby differentiating and promoting recovery 
(Chari, 2007; Compston and Coles, 2008). OPCs are converted to a regenerative phenotype by several 
transcription factors that play important roles in OL development, and it is observed that this response 
generally occurs during acute phases of myelination and during early remyelination. This indicates 
that OPC regenerative phenotype is a transition that recapitulates developmental programs (Gallo and 
Deneen, 2014; Lu et al., 2002). Since these molecular changes are what lead OPCs to differentiation 
and consequent remyelination in disease context, the results in this work might be informative in the 
manipulation and drive of these processes. Here we show molecular singularities in OPCs and 
myelinating subpopulations of OL lineage, some of them including transcription factors. Moreover, 
their distribution is described in areas of the brain and spinal cord, also giving information about their 
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developmental origin. By integrating this information it might be possible to trace a path of 
differentiation and target areas where demyelination is happening, ensuring a more efficient way of 
remyelination. Moreover, OPCs display distinct myelination potential based on their location, either in 
the brain or spinal cord. Indeed, OPCs generate myelin sheath lengths that are a reflection of their in 
vivo origin, demonstrating a regional identity prior to differentiation. Additionally, there are 
differences in the settling positions assumed by OL lineage cells based on their ventral versus dorsal 
origin (Bechler et al., 2015; Tripathi et al., 2011). Also, the remyelinating potential of OPCs decreases 
from early postnatal development towards adulthood (Gallo and Deneen, 2014). Therefore, the 
manipulation of the transcription and differentiation profile of OPCs is of extreme relevance in order 
to bring forth a strategy for inducing remyelination in older individuals suffering from MS. Future 
epigenetic studies, joined with imaging and immunological approaches, have the potential to further 
understand the mechanisms that regulate remyelination and thereby manipulate this intricate process 
to some extent.  
	 27	
References 
 
Aguirre, A., Dupree, J.L., Mangin, J.M., and Gallo, V. (2007). A functional role for EGFR signaling 
in myelination and remyelination. Nat. Neurosci. 10, 990–1002. 
 
Barnett, M.H., and Prineas, J.W. (2004). Relapsing and Remitting Multiple Sclerosis: Pathology of the 
Newly Forming Lesion. Ann. Neurol. 55, 458–468. 
 
Bartzokis, G., Lu, P.H., Heydari, P., Couvrette, A., Lee, G.J., Kalashyan, G., Freeman, F., Grinstead, 
J.W., Villablanca, P., Finn, J.P., et al. (2012). Multimodal Magnetic Resonance Imaging Assessment 
of White Matter Aging Trajectories Over the Lifespan of Healthy Individuals. Biol. Psychiatry 
72,1026–1034. 
 
Bauer, N.G., Richter-Landsberg, C., and Ffrench-Constant, C. (2009). Role of the oligodendroglial 
cytoskeleton in differentiation and myelination. Glia 57, 1691–1705. 
 
Baumann, N., and Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the mammalian 
central nervous system. Physiol. Rev. 81, 871–927. 
 
Bechler, M.E., Byrne, L., and Ffrench-Constant, C. (2015). CNS Myelin Sheath Lengths Are an 
Intrinsic Property of Oligodendrocytes. Curr. Biol. 25, 2411–2416. 
 
Bengtsson, S.L., Nagy, Z., Skare, S., Forsman, L., Forssberg, H., and Ullén, F. (2005). Extensive 
piano practicing has regionally specific effects on white matter development. Nat. Neurosci. 8, 1148–
1150. 
 
Bercury, K.K., and Macklin, W.B. (2015). Dynamics and mechanisms of CNS myelination. Dev. Cell 
32, 447–458. 
 
Bjartmar, C., and Trapp, B.D. (2001). Axonal and neuronal degeneration in multiple sclerosis: 
mechanisms and functional consequences. Curr. Opin. Neurol. 14, 271–278. 
 
Bordeaux, J., Welsh, A.W., Agarwal, S., Killiam, E., Baquero, M.T., Hanna, J.A., Anagnostou, V.K., 
and Rimm, D.L. (2010). Antibody validation. Biotechniques 48, 197–209. 
 
Byme, J.H., Heidelberger Ruth, and Waxham M Neal (2014). From Molecules to Network (Third 
Edition) (Academic Press)  
 
Cai, J., Qi, Y., Hu, X., Tan, M., Liu, Z., Zhang, J., Li, Q., Sander, M., and Qiu, M. (2005). Generation 
of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and 
Shh signaling. Neuron 45, 41–53. 
 
Campbell, K., and Götz, M. (2002). Radial glia: Multi-purpose cells for vertebrate brain development. 
Trends Neurosci. 25, 235–238. 
 
Chari, D.M. (2007). Remyelination In Multiple Sclerosis. Int. Review of Neurobiology 79, 589–620.  
 
Compston, A., and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502–1517. 
 
Decimo, I., Bifari, F., Krampera, M., and Fumagalli, G. (2012). Neural stem cell niches in health and 
diseases. Curr. Pharm. Des. 18, 1755–1783. 
 
Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H., and Gotz, M. (2008). Progeny of Olig2-
Expressing Progenitors in the Gray and White Matter of the Adult Mouse Cerebral Cortex. J. 
Neurosci. 28, 10434–10442. 
	 28	
Edfors, F., Danielsson, F., Hallström, B.M., Käll, L., Lundberg, E., Pontén, F., Forsström, B., and 
Uhlén, M. (2016). Gene‐specific correlation of RNA and protein levels in human cells and tissues. 
Mol. Syst. Biol. 12, 883. 
 
Evans, J.F., Islam, S., Urade, Y., Eguchi, N., and Ragolia, L. (2013). The lipocalin-type prostaglandin 
D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early 
hypothalamic-pituitary-adrenal axis hyperactivity. J. Endocrinol. 216, 169–180. 
 
Gallo, V., and Deneen, B. (2014). Glial development: The crossroads of regeneration and repair in the 
CNS. Neuron 83, 283–308. 
 
Gilbert, S.F. (2010). Developmental Biology (Sinauer Associates Inc.). 
 
Goldenberg, M.M. (2012). Multiple sclerosis review. Pharmacy & Therapeutics 37, 175–184. 
 
Gruda, M.C., van Amsterdam, J., Rizzo, C.A., Durham, S.K., Lira, S., and Bravo, R. (1996). 
Expression of FosB during mouse development: normal development of FosB knockout mice. 
Oncogene 12, 2177–2185. 
 
Hans S Keirstead, W.F.B. (1999). The role of oligodendrocytes and oligodendrocyte progenitors in 
CNS remyelination. Adv. Exp. Med. Biol. 468, 183–197. 
 
Herculano-Houzel, S. (2014). The glia/neuron ratio: How it varies uniformly across brain structures 
and species and what that means for brain physiology and evolution. Glia 62, 1377–1391. 
 
Hofmann, K., Rodriguez-Rodriguez, R., Gaebler, A., Casals, N., Scheller, A., and Kuerschner, L. 
(2017). Astrocytes and oligodendrocytes in grey and white matter regions of the brain metabolize fatty 
acids. Sci. Rep. 7, 1–12. 
 
Howat, W.J., Lewis, A., Jones, P., Kampf, C., Pontén, F., van der Loos, C.M., Gray, N., Womack, C., 
and Warford, A. (2014). Antibody validation of immunohistochemistry for biomarker discovery: 
Recommendations of a consortium of academic and pharmaceutical based histopathology researchers. 
Methods 70, 34–38. 
 
Ishibashi, T., Dakin, K.A., Stevens, B., Lee, P.R., Kozlov, S. V., Stewart, C.L., and Fields, R.D. 
(2006). Astrocytes promote myelination in response to electrical impulses. Neuron 49, 823–832. 
 
Jang, S.W., LeBlanc, S.E., Roopra, A., Wrabetz, L., and Svaren, J. (2006). In vivo detection of Egr2 
binding to target genes during peripheral nerve myelination. J. Neurochem. 98, 1678–1687. 
 
Jansen, R.P. (2001). mRNA localization: Message on the move. Nat. Rev. Mol. Cell Biol. 2, 247–256. 
 
Kandel, E.R., Hudspeth, A.J., Jessell, T.M., Schwartz, J.H., and Siegelbaum, S.A. (2013). Principles 
of Neural Science (McGraw-Hill). 
 
Kessaris, N., Fogarty, M., Iannarelli, P., Grist, M., Wegner, M., and Richardson, W.D. (2006).  
Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic 
lineage. Nat. Neurosci. 9, 173–179. 
 
Kuboyama, K., Fujikawa, A., Suzuki, R., and Noda, M. (2015). Inactivation of Protein Tyrosine 
Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of 
Differentiation of Oligodendrocyte Precursor Cells. J. Neurosci. 35, 12162–12171. 
 
Lassmann, H., Brück, W., and Lucchinetti, C. (2001). Heterogeneity of multiple sclerosis 
pathogenesis: Implications for diagnosis and therapy. Trends Mol. Med. 7, 115–121. 
	 29	
Lebel, C., Walker, L., Leemans, A., Phillips, L., and Beaulieu, C. (2008). Microstructural maturation 
of the human brain from childhood to adulthood. NeuroImage 40, 1044–1055. 
 
Liu, Y., Beyer, A., and Aebersold, R. (2016). On the Dependency of Cellular Protein Levels on 
mRNA Abundance. Cell 165, 535–550. 
 
Lu, Q.R., Yuk, D.I., Alberta, J.A., Zhu, Z., Pawlitzky, I., Chan, J., McMahon, A.P., Stiles, C.D., and 
Rowitch, D.H. (2000). Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH 
proteins in the mammalian central nervous system. Neuron 25, 317–329. 
 
Lu, Q.R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C.D., and Rowitch, D.H. (2002). Common 
developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. 
Cell 109, 75–86. 
 
Maldonado, P.P., Velez-Fort, M., Levavasseur, F., and Angulo, M.C. (2013). Oligodendrocyte 
Precursor Cells Are Accurate Sensors of Local K+ in Mature Gray Matter. J. Neurosci. 33, 2432–
2442. 
 
Mariotto, A., Pavlova, O., Park, H.S., Huber, M., and Hohl, D. (2016). HOPX: The Unusual 
Homeodomain-Containing Protein. J. Invest. Dermatol. 136, 905–911. 
 
Marques, S., Zeisel, A., Codeluppi, S., Bruggen, D. Van, Falcão, A.M., Xiao, L., Li, H., Häring, M., 
Hochgerner, H., Romanov, R.A., et al. (2016). Oligodendrocyte heterogeneity in the mouse juvenile 
and adult central nervous system. Science (80-. ). 352, 1326–1329. 
 
Menn, B., Garcia-Verdugo, J.M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., and Alvarez-Buylla, 
A. (2006). Origin of Oligodendrocytes in the Subventricular Zone of the Adult Brain. J. Neurosci. 26, 
7907–7918. 
 
Miller, R.H. (2002). Regulation of oligodendrocyte development in the vertebrate CNS. Prog. 
Neurobiol. 67, 451–467. 
 
Mitew, S., Hay, C.M., Peckham, H., Xiao, J., Koenning, M., and Emery, B. (2014). Mechanisms 
regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience 
276, 29–47. 
 
Mtui, E., Gruener, G., & Fitzgerald, M.T. (2011). Clinical Neuroanatomy and Neuroscience. Elsevier 
Health Sciences 
 
Nadarajah, B., Alifragis, P., Wong, R.O.L., and Parnavelas, J.G. (2003). Neuronal migration in the 
developing cerebral cortex: observations based on real-time imaging. Cereb. Cortex 13, 607–611. 
 
Ohtani, T., Nestor, P.G., Bouix, S., Saito, Y., Hosokawa, T., and Kubicki, M. (2014). Medial frontal 
white and gray matter contributions to general intelligence. PLoS One 9, 1–17. 
 
Richardson, W.D., Kessaris, N., and Pringle, N. (2006). Oligodendrocyte wars. Nat. Rev. Neurosci. 7, 
11–18. 
 
Richardson, W.D., Young, K.M., Tripathi, R.B., and McKenzie, I. (2011). NG2-glia as Multipotent 
Neural Stem Cells: Fact or Fantasy? Neuron 70, 661–673. 
 
del Río-Hortega, P. (1928). Tercera aportacion al conocimiento morfologico e interpretacion funcional 
de la oligodendroglia. Volume 14 de Memorias de la Real Sociedad Española de Historia Natural 
 
 
	 30	
Rowitch, D.H. (2004). Glial specification in the vertebrate neural tube. Nat. Rev. Neurosci. 5, 409–
419. 
 
Rowitch, D.H., and Kriegstein, A.R. (2010). Developmental genetics of vertebrate glial-cell 
specification. Nature 468, 214–222. 
 
Scholz, J., Klein, M.C., Behrens, T.E.J., and Johansen-Berg, H. (2009). Training induces changes in 
white-matter architecture. Nat. Neurosci. 12, 1370–1371. 
 
Simons, M., and Nave, K. (2015). Oligodendrocytes : Myelination and Axonal Support. Cold Spring 
Harb Perspect Biol 10. 1–16. 
 
Smith, R. (2004). Moving molecules: mRNA trafficking in mammalian oligodendrocytes and neurons. 
Neuroscientist 10, 495–500. 
 
Squire, L.R., Bloom, F.E., Spitzer, N.C., Lac, S. du, Ghosh, A., and Berg, D. (2008). Fundamental 
Neuroscience (Academic Press). 
 
Tekki-Kessaris, N., Woodruff, R., Hall,  a C., Gaffield, W., Kimura, S., Stiles, C.D., Rowitch, D.H., 
and Richardson, W.D. (2001). Hedgehog-dependent oligodendrocyte lineage specification in the 
telencephalon. Development 128, 2545–2554. 
 
Tomassy, G.S., and Fossati, V. (2014). How big is the myelinating orchestra? Cellular diversity within 
the oligodendrocyte lineage: facts and hypotheses. Front. Cell. Neurosci. 8, 1–11. 
 
Trapnell, C. (2015). Defining cell types and states with single-cell genomics. Genome Res. 25, 1491–
1498. 
 
Tripathi, R.B., Clarke, L.E., Burzomato, V., Kessaris, N., Anderson, P.N., Attwell, D., and 
Richardson, W.D. (2011). Dorsally and Ventrally Derived Oligodendrocytes Have Similar Electrical 
Properties but Myelinate Preferred Tracts. J. Neurosci. 31, 6809–6819. 
 
Uhlen, M., Bandrowski, A., Carr, S., Edwards, A., Ellenberg, J., Lundberg, E., Rimm, D.L., 
Rodriguez, H., Hiltke, T., Snyder, M., et al. (2016). A proposal for validation of antibodies. Nat. 
Methods 13, 823–827. 
 
Wang, F., Flanagan, J., Su, N., Wang, L.C., Bui, S., Nielson, A., Wu, X., Vo, H.T., Ma, X.J., and Luo, 
Y. (2012). RNAscope: A novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded 
tissues. J. Mol. Diagnostics 14, 22–29. 
 
Zeisel, A., Munoz-Manchado, A.B., Codeluppi, S., Lonnerberg, P., La Manno, G., Jureus, A., 
Marques, S., Munguba, H., He, L., Betsholtz, C., et al. (2015). Cell types in the mouse cortex and 
hippocampus revealed by single-cell RNA-seq. Science (80-. ). 347, 1138–1142. 
 
Zuchero, J.B., and Barres, B.A. (2015). Glia in mammalian development and disease. Development 
142, 3805–3809. 
  
	 31	
Supplementary data 
 
   
    
 
Supplementary figure 1. Standard immunohistochemistry staining for Egr2+ cells and GFP+ cells in the juvenile 
mouse. Immunohistochemistry targeting MOL1 (Egr2) and Pdgfra+ cells and progeny (GFP) in cortex (A), corpus callosum 
(B), dorsal horn (C) and corticospinal tract (D). Experimental mice were recombined on P3-5 and tissue was collected on 
P20. Yellow arrows indicate signal colocalization between Egr2+ cells and GFP+ cells. Scale bars represent 50µm. 
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Supplementary figure 2. Standard immunohistochemistry staining for FosB+ cells and GFP+ cells in the juvenile 
mouse. Immunohistochemistry targeting MOL1 and VLMCs (FosB), and Pdgfra+ cells and progeny (GFP) in cortex (A), 
corpus callosum (B), dorsal horn (C) and corticospinal tract (D). Experimental mice were recombined on P3-5 and tissue was 
collected on P20. Yellow arrows indicate signal colocalization between FosB+ cells and GFP+ cells. Scale bars represent 
50µm. 
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Supplementary figure 3. In situ hybridization coupled with immunohistochemistry staining for Egr2 (probe) and 
GFP+ cells in the adult mouse In situ hybridization targeting MOL1 (Egr2), and Pdgfra+ cells and progeny (GFP) in cortex 
(A), corpus callosum (B), dorsal horn (C) and corticospinal tract (D). Experimental mice were recombined on P3-5 and tissue 
was collected on P20. Yellow arrows indicate signal colocalization between Egr2 RNA molecules and GFP+ cells. Scale bars 
represent 50µm. 
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Supplementary figure 4. In situ hybridization coupled with immunohistochemistry staining for Ptgds (antibody and 
probe) and GFP+ cells in the adult mouse. RNAscope in situ hybridization combined with standard immunohistochemistry 
targeting MOL5 and 6 (Ptgds - antibody and probe) and Pdgfra+ cells and progeny (GFP - antibody) in cortex (A), corpus 
callosum (B) and dorsal horn (C). Experimental mice were recombined P3-5 and tissue was collected on P60. Yellow arrows 
indicate signal colocalization between Ptgds RNA probe/antibody and GFP+ cells. Scale bars represent 50µm. 
 
 
 
Supplementary figure 5. Percentage of MOL5/6 and OPCs-COP in the adult mouse CNS. Percentage of fate mapped 
MOL5/6 and OPCs-COP originated from the embryonic and postnatal developmental waves. Data reported as mean ± 
standard error of the mean (SEM), n=3. 
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